[1] Royal Marsden Hosp, London SW3 6JJ, England
[2] IOV IRCCS Melanoma Oncol Unit, Melanoma Canc Unit, Padua, Italy
[3] Univ Colorado, Ctr Canc, Div Med Oncol, Aurora, CO USA
[4] Aix Marseille Univ, Hop La Timone, APHM, Dept Dermatol & Skin Canc, Marseille, France
[5] Baylor Charles Sammons Canc Ctr, Hematol Med Oncol, Dallas, TX USA
[6] Univ Michigan, Med Oncol, Ann Arbor, MI 48109 USA
[7] South Wales Wales Canc Inst Singleton Hosp, Oncol Clin Trials Unit, Swansea, W Glam, Wales
[8] Univ Toronto, Princess Margaret Hosp, Clin Studies Resource Ctr, Toronto, ON, Canada
[9] Tasman Oncol Res, Dept Hlth, South Gold Coast, Qld, Australia
[10] Melanoma Inst Australia, Sydney, NSW, Australia
[11] Univ Sydney, Med Oncol, Sydney, NSW 2006, Australia
[12] UZ Leuven, Med Oncol, Leuven, Belgium
[13] Univ Paris Diderot, Hop St Luis, Dept Dermatol, Paris, France
[14] Chaim Sheba Med Ctr, Ella Inst Treatment & Res Melanoma & Skin Canc, Inst Oncol, IL-52621 Tel Hashomer, Israel
[15] Ctr Hosp Lyon Sud, Dept Dermatol, F-69310 Pierre Benite, France
[16] Univ Hosp, German Canc Res Ctr, Dept Dermatol, Heidelberg, Germany
[17] Natl Ctr Tumor Dis, Heidelberg, Germany
[18] Christie NHS Fdn Trust, Med Oncol, Manchester, Lancs, England
[19] Bristol Myers Squibb Co, Global Clin Res, Princeton, NJ USA
[20] Bristol Myers Squibb Co, Global Biometr Sci, Hopewell, NJ USA
[21] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med, Boston, MA 02115 USA
[22] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[23] Weill Cornell Med Coll, Melanoma Serv, New York, NY USA
[24] Weill Cornell Med Coll, Immunotherapeut Serv, New York, NY USA